Perilla seed oil as an adjunctive treatment with a statin improves lipid profiles in elderly: a post hoc data analysis

Author:

Chanapuk Rapeebhorn1,Sriya Kusuma1,Tungsukruthai Parunkul1,Pattaraarchachai Junya1,Mungtaweepongsa Sombat2,Kamalashiran Chuntida1

Affiliation:

1. Chulabhorn International College of Medicine, Thammasat University

2. Thammasat University

Abstract

Abstract Our previous study showed the potential benefit of perilla seed oil for improving lipid profiles in the elderly. We conducted a post hoc data analysis of our previous study to investigate the efficacy of perilla seed oil for improving lipid profiles in the elderly after the 6-month treatment. A total number of 182 patients with mild to moderate dementia were divided into four groups: a perilla seed oil and statins group (G1), a perilla seed oil group (G2), a statins group (G3), and the last group without perilla seed oil and statins (G4). The data were collected from Thammasat Hospital's electronic information system. Data on patients’ lipid levels and other laboratory results were collected before and after the 6-month treatment. Laboratory results were analyzed using One-way ANOVA and paired t-test analysis by SPSS software. The laboratory results after the treatment revealed that the mean values of total cholesterol, LDL-C, and LDL-C/HDL-C ratio from lipid profiles in G1, G2, and G3 decreased. In G1, total cholesterol decreased from 163.93 to 151.68 mg/dL (p-value = 0.00), and LDL-C decreased from 88.88 to 77.34 mg/dL, while the LDL-C/HDL-C ratio decreased from 1.73 to 0.24. In conclusion, the research showed that perilla seed oil decreased non-HDL cholesterols, especially LDL-C when combined with a statin. Therefore, perilla seed oil, in combination with a statin, enhances favorable lipid profiles.

Publisher

Research Square Platform LLC

Reference23 articles.

1. Cholesterol: the good, the bad, and the ugly - therapeutic targets for the treatment of dyslipidemia;Elshourbagy NA;Med Princ Pract,2014

2. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Arnett DK;Circulation,2019

3. Lipid profile and effect of statin treatment in pooled phase II and phase III baricitinib studies;Taylor PC;Annals of the Rheumatic Diseases,2018

4. Statin therapy in patients with acute coronary syndrome: low-density lipoprotein cholesterol goal attainment and effect of statin potency;Phrommintikul A;Therapeutics and Clinical Risk Management,2015

5. Cardiovascular Risk Factors Predicted MACE Outcomes in Chronic Total Occlusion Patients Undergoing Percutaneous Coronary Intervention at Thammasat University Hospital;Witoonchart K;Science & Technology Asia,2022

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3